These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 7310681)

  • 21. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic clearance of lidocaine during N2O anesthesia in dogs.
    Burney RG; DiFazio CA
    Anesth Analg; 1976; 55(3):322-5. PubMed ID: 945010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clearly there is intrinsic value in intrinsic clearance.
    Roberts RK; Schenker S
    Hepatology; 1983; 3(6):1036-8. PubMed ID: 6354902
    [No Abstract]   [Full Text] [Related]  

  • 25. Lidocaine kinetics predicted by indocyanine green clearance.
    Zito RA; Reid PR
    N Engl J Med; 1978 May; 298(21):1160-3. PubMed ID: 651945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of penbutolol on lidocaine kinetics.
    Ochs HR; Skanderra D; Abernethy DR; Greenblatt DJ
    Arzneimittelforschung; 1983; 33(12):1680-1. PubMed ID: 6686773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of prolonged recumbency on drug disposition.
    Kates RE; Harapat SR; Keefe DL; Goldwater D; Harrison DC
    Clin Pharmacol Ther; 1980 Nov; 28(5):624-8. PubMed ID: 7438681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of heart insufficiency and cardiogenic shock on pharmacokinetics].
    Paumgartner G
    Internist (Berl); 1982 Aug; 23(8):441-4. PubMed ID: 6752084
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of nadolol and propranolol on plasma lidocaine clearance.
    Schneck DW; Luderer JR; Davis D; Vary J
    Clin Pharmacol Ther; 1984 Nov; 36(5):584-7. PubMed ID: 6488678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of ranitidine on the disposition of lignocaine.
    Robson RA; Wing LM; Miners JO; Lillywhite KJ; Birkett DJ
    Br J Clin Pharmacol; 1985 Aug; 20(2):170-3. PubMed ID: 4041336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of norepinephrine and prostaglandin E1 on pharmacokinetics of lidocaine in isolated perfused rat liver.
    Matsuura Y; Nishi S; Kariya N; Shimadzu K; Asada A
    Life Sci; 2001 Mar; 68(18):2123-9. PubMed ID: 11324717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dynamic liver function study using the lidocaine test].
    Sídlová K; Průsa R
    Cas Lek Cesk; 2000 Sep; 139(19):604-5. PubMed ID: 11192753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation.
    Pang KS; Rowland M
    J Pharmacokinet Biopharm; 1977 Dec; 5(6):655-80. PubMed ID: 599412
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of cholestyramine and parenteral nutrition on hepatic metabolism of lidocaine: a study using isolated rat liver perfusion.
    Zaman N; Tam YK; Jewel LD; Coutts RT
    JPEN J Parenter Enteral Nutr; 1996; 20(5):349-56. PubMed ID: 8887904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass.
    Autschbach R; Falk V; Lange H; Oellerich M; Walther T; Mohr FW; Dalichau H
    Thorac Cardiovasc Surg; 1996 Apr; 44(2):76-80. PubMed ID: 8782332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of inflammation on the metabolism of antipyrine, lidocaine and propranolol in isolated rat hepatocytes.
    Chindavijak B; Belpaire FM; Bogaert MG
    Pharmacology; 1988; 36(4):279-82. PubMed ID: 3380881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemodialysis clearance of total and unbound lidocaine.
    Jacobi J; McGory RW; McCoy H; Matzke GR
    Clin Pharm; 1983; 2(1):54-7. PubMed ID: 6883930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The reduction of lidocaine clearance by dl-propranolol: an example of hemodynamic drug interaction.
    Branch RA; Shand DG; Wilkinson GR; Nies AS
    J Pharmacol Exp Ther; 1973 Feb; 184(2):515-9. PubMed ID: 4688187
    [No Abstract]   [Full Text] [Related]  

  • 39. Lidocaine metabolism in isolated perfused liver from streptozotocin-induced diabetic rats.
    Gawronska-Szklarz B; Musial HD; Loniewski I; Paprota B; Drozdzik M
    J Pharm Pharmacol; 2006 Aug; 58(8):1073-7. PubMed ID: 16872554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discussions on the hepatic well-stirred model: Re-derivation from the dispersion model and re-analysis of the lidocaine data.
    Dong J; Park MS
    Eur J Pharm Sci; 2018 Nov; 124():46-60. PubMed ID: 30102979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.